• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

    36.65 -4.36 (-10.64%)
    Streaming Delayed Price Updated: 1:19 PM EST, Feb 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,502,867
    Open 36.14
    Bid (Size) 36.64 (100)
    Ask (Size) 36.70 (200)
    Prev. Close 41.01
    Today's Range 32.63 - 39.50
    52wk Range 36.67 - 90.32
    Shares Outstanding 8,168,788
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Soleno Therapeutics (NASDAQ:SLNO) Beats Q4 2025 Estimates Amid Cautious Market Reaction to VYKAT XR Launch ↗
    Via Chartmill
    News headline image
    Soleno (SLNO) Q4 2025 Earnings Call Transcript ↗
    Soleno (SLNO) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings

    Performance

    YTD
    -22.3%
    -22.3%
    1 Month
    -14.4%
    -14.4%
    3 Month
    -26.0%
    -26.0%
    6 Month
    -45.9%
    -45.9%
    1 Year
    -18.3%
    -18.3%

    More News

    Read More
    News headline image
    SLNO INVESTOR ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Fraud Investigation
    From Kirby McInerney LLP
    Via GlobeNewswire
    News headline image
    SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc.
    From Kirby McInerney LLP
    Via Business Wire
    News headline image
    SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP
    From Kirby McInerney LLP
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Soleno Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (SLNO)
    From Kirby McInerney LLP
    Via Business Wire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Rhythm Pharmaceuticals Faces Gravity: FDA Delays and Valuation Pressures Cool 2025’s Biotech Darling
    Via MarketMinute
    Topics ETFs Economy World Trade
    News headline image
    Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Soleno Therapeutics Unveils $100 Million Buyback Citing 'Underappreciated' Future ↗
    Via Benzinga
    News headline image
    PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    SLNO INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Soleno Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
    From Robbins Geller Rudman & Dowd LLP
    Via Business Wire
    News headline image
    Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Wednesday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Super Micro Computer Posts Downbeat Q1 Results, Joins Pinterest, Axon Enterprise And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    These stocks that are showing activity before the opening bell on Wednesday. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga

    Frequently Asked Questions

    Is Soleno Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Soleno Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Soleno Therapeutics, Inc. - Common Stock trade on?
    Soleno Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Soleno Therapeutics, Inc. - Common Stock?
    The ticker symbol for Soleno Therapeutics, Inc. - Common Stock is SLNO on the Nasdaq Stock Market
    What is the current price of Soleno Therapeutics, Inc. - Common Stock?
    The current price of Soleno Therapeutics, Inc. - Common Stock is 36.65
    When was Soleno Therapeutics, Inc. - Common Stock last traded?
    The last trade of Soleno Therapeutics, Inc. - Common Stock was at 02/26/26 01:19 PM ET
    What is the market capitalization of Soleno Therapeutics, Inc. - Common Stock?
    The market capitalization of Soleno Therapeutics, Inc. - Common Stock is 299.35M
    How many shares of Soleno Therapeutics, Inc. - Common Stock are outstanding?
    Soleno Therapeutics, Inc. - Common Stock has 299M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.